» Authors » G Raab

G Raab

Explore the profile of G Raab including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 1156
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Millard A, Raab G, Lewsey J, Eaglesham P, Craig P, Ralston K, et al.
Int J Equity Health . 2015 Nov; 14:142. PMID: 26606921
Background: Little is known about the interaction between socio-economic status and 'protected characteristics' in Scotland. This study aimed to examine whether differences in mortality were moderated by interactions with social...
2.
Seidel A, Soballa V, Raab G, Frank H, Greim H, Grimmer G, et al.
Environ Toxicol Pharmacol . 2011 Jul; 5(3):179-96. PMID: 21781864
Regio- and stereoselective metabolism mediated by cytochrome P450 (CYP) and metabolite-dependent cytotoxicity of benzo[c]phenanthrene (B[c]Ph) and its trans-3,4-dihydrodiol, the metabolic precursor of the carcinogenic fjord-region B[c]Ph-3,4-dihydrodiol 1,2-epoxides (B[c]PhDE), were investigated...
3.
Jacob J, Raab G, Soballa V, Schmalix W, Grimmer G, Greim H, et al.
Environ Toxicol Pharmacol . 2011 Jul; 1(1):1-11. PMID: 21781657
V79 Chinese hamster cells genetically engineered for rat cytochromes P450 1A1, 1A2, 2B1 and human cytochromes P450 1A1, 1A2, 2A6, 2E1, and 3A4 are being applied in metabolism studies on...
4.
Bradbury A, Adam D, Bell J, Forbes J, Fowkes F, Gillespie I, et al.
Health Technol Assess . 2010 Mar; 14(14):1-210, iii-iv. PMID: 20307380
Objective: To compare a 'bypass-surgery-first' with a 'balloon-angioplasty-first' revascularisation strategy in patients with severe limb ischaemia (SLI) due to infrainguinal disease requiring immediate/early revascularisation. Design: A stratified randomised controlled trial....
5.
Lux M, Hartmann M, Jackisch C, Raab G, Schneeweiss A, Possinger K, et al.
Breast Cancer Res Treat . 2009 Jan; 117(2):305-17. PMID: 19130218
Therapy decisions in advanced breast cancer (ABC) increasingly require assessment not only of treatment efficacy but also of cost-effectiveness. To this end, we performed a cost-utility analysis by comparing treatment...
6.
Salter A, Raab G, Day S
Clin Trials . 2006 Oct; 3(5):421-30. PMID: 17060216
Background: Data from clinical trials where the endpoint is a single survival time are readily analysed by standard methods, most commonly using a semi-parametric proportional hazards approach. However, when the...
7.
Adam D, Beard J, Cleveland T, Bell J, Bradbury A, Forbes J, et al.
Lancet . 2005 Dec; 366(9501):1925-34. PMID: 16325694
Background: The treatment of rest pain, ulceration, and gangrene of the leg (severe limb ischaemia) remains controversial. We instigated the BASIL trial to compare the outcome of bypass surgery and...
8.
von Minckwitz G, Blohmer J, Raab G, Lohr A, Gerber B, Heinrich G, et al.
Ann Oncol . 2004 Dec; 16(1):56-63. PMID: 15598939
Background: Response to the first two cycles of preoperative chemotherapy might differentiate subgroups of breast cancer patients with high or minimal chances for a pathologic complete response (pCR) and may...
9.
von Minckwitz G, Raab G, Schutte M, Hilfrich J, Blohmer J, Gerber B, et al.
Zentralbl Gynakol . 2001 Dec; 123(9):497-504. PMID: 11709742
Objective: The German Adjuvant Breast Cancer Study Group (GABG) conducts trials of preoperative chemotherapy in patients with primary breast cancer using a combination of doxorubicin and docetaxel (ADoc). - Patients...
10.
Raab G, Van den Bergh M
Zentralbl Gynakol . 2001 Sep; 123(8):444-9. PMID: 11562807
Purpose: To simplify clinical routine and to improve medical quality without exceeding the existing resources. Intensifying communication and cooperation between all institutions of patients' health care. The huge amount of...